The $500 million deal will expand CareFusion’s Specialty Disposables business by adding more distribution channels and new anesthesiology products. Vital Signs will be CareFusion’s eighth acquisition since 2010.
“The acquisition of Vital Signs is well-aligned to our long-term growth strategy, helping us create scale in our Procedural Solutions call points and increas[ing] our presence outside of the United States,” said Kieran T. Gallahue, chairman and CEO of CareFusion, in a news release. “Together, CareFusion and Vital Signs have the [research and development], manufacturing and go-to-market resources to drive innovation, invest for growth and better support customers in major geographic markets.”
More Articles on the Health IT Market:
Allscripts Reports 3Q Loss
Experian Acquires Passport Health Communications for $850M
Health IT M&A Activity: MEDSEEK Acquires SymphonyCare, WebMD Acquires Avado
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
